Oral B. velezensis HBXN2020 spores alleviated S. Typhimurium-induced experimental mouse colitis.
(A) In vitro Bacterial competition between STm and B. velezensis HBXN2020. STm were co-incubated with B. velezensis HBXN2020 at various ratios at 37°C with shaking. The growth of STm was reflected by bacterial counting per hour. (B) Experimental design for treatment in this study. Orally administrated with either PBS, or B. velezensis HBXN2020 spores by gavage at days 1, 3, and 5 after STm infection (5× 107 CFU/mouse), respectively. All mice were euthanized at day 7 after STm infection. (C) Bacterial count of STm in mouse feces. Fecal samples were collected per day after STm infection and resuspended in sterile PBS (0.1 g of fecal resuspended in 1 mL of sterile PBS). One hundred microliters of each sample performed a serial of 10-fold dilutions and spread on selective agar plates (50 µg mL-1 kanamycin) and incubated at 37°C for 12 h before bacterial counting. The bacterial loads of STm in (D) ileum, (E) cecum, and (F) colon. The cecum and colon were harvested and then homogenized. Statistical signifcance was evaluated using Student’s t-test (*, P < 0.05, **, P < 0.01, and ***, P < 0.001). (G) Daily body weight changes and (H) daily disease activity index (DAI) scores of mice with different treatment groups. Data were shown as mean values ± SEM (n = 8). Statistical signifcance was evaluated using one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test. *, P < 0.05, **, P < 0.01, and ***, P < 0.001 relative to Control group; #, P < 0.05, ##, P < 0.01, ###, P < 0.001 relative to STm + HBXN2020 group. (I) Colonic tissue images. (J) The length of the colon from per group (n = 8). Statistical signifcance was evaluated using one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test (*, P < 0.05, **, P < 0.01, and ***, P < 0.001).